MannKind Corp (MNKD) stock
MNKDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30127% above fair value
$4.07+0.00 (0.00%)
Close on Nov 18, 2026Market cap $1.31BP/E –Yield –
MannKind revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
MannKind's revenue for the twelve months ending Jun 30, 2026 was $393.63M, up 30.5% year over year. For fiscal 2025 it was $348.97M, up 22.2% from the year before. The highest annual figure on record is $348.97M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $348.97M | +22.2% |
| FY2024 | Dec 31, 2024 | $285.50M | +43.5% |
| FY2023 | Dec 31, 2023 | $198.96M | +99.4% |
| FY2022 | Dec 31, 2022 | $99.77M | +32.2% |
| FY2021 | Dec 31, 2021 | $75.44M | +15.8% |
| FY2020 | Dec 31, 2020 | $65.14M | +3.3% |
| FY2019 | Dec 31, 2019 | $63.04M | +126.3% |
| FY2018 | Dec 31, 2018 | $27.86M | +137.2% |
| FY2017 | Dec 31, 2017 | $11.75M | -93.3% |
| FY2016 | Dec 31, 2016 | $174.76M | – |
| FY2015 | Dec 31, 2015 | $0 | – |
| FY2014 | Dec 31, 2014 | $0 | – |
| FY2013 | Dec 31, 2013 | $0 | -100.0% |
| FY2012 | Dec 31, 2012 | $35.00K | -30.0% |
| FY2011 | Dec 31, 2011 | $50.00K | -46.2% |
| FY2010 | Dec 31, 2010 | $93.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $109.37M | +42.9% |
| Q1 FY2026 | Mar 31, 2026 | $90.17M | +15.1% |
| Q4 FY2025 | Dec 31, 2025 | $111.96M | +45.8% |
| Q3 FY2025 | Sep 30, 2025 | $82.13M | +17.2% |
| Q2 FY2025 | Jun 30, 2025 | $76.53M | +5.7% |
| Q1 FY2025 | Mar 31, 2025 | $78.35M | +18.2% |
| Q4 FY2024 | Dec 31, 2024 | $76.78M | +31.3% |
| Q3 FY2024 | Sep 30, 2024 | $70.08M | +36.7% |
| Q2 FY2024 | Jun 30, 2024 | $72.39M | +48.9% |
| Q1 FY2024 | Mar 31, 2024 | $66.26M | +63.1% |
| Q4 FY2023 | Dec 31, 2023 | $58.47M | +62.2% |
| Q3 FY2023 | Sep 30, 2023 | $51.25M | +56.1% |
| Q2 FY2023 | Jun 30, 2023 | $48.61M | +157.3% |
| Q1 FY2023 | Mar 31, 2023 | $40.63M | +238.8% |
| Q4 FY2022 | Dec 31, 2022 | $36.06M | +188.1% |
| Q3 FY2022 | Sep 30, 2022 | $32.83M | +47.8% |
| Q2 FY2022 | Jun 30, 2022 | $18.89M | -18.8% |
| Q1 FY2022 | Mar 31, 2022 | $11.99M | -31.2% |
| Q4 FY2021 | Dec 31, 2021 | $12.52M | -32.1% |
| Q3 FY2021 | Sep 30, 2021 | $22.21M | +44.7% |
| Q2 FY2021 | Jun 30, 2021 | $23.28M | +54.0% |
| Q1 FY2021 | Mar 31, 2021 | $17.44M | +7.4% |
| Q4 FY2020 | Dec 31, 2020 | $18.44M | +15.3% |
| Q3 FY2020 | Sep 30, 2020 | $15.35M | +5.2% |
| Q2 FY2020 | Jun 30, 2020 | $15.11M | +0.7% |
| Q1 FY2020 | Mar 31, 2020 | $16.24M | -7.0% |
| Q4 FY2019 | Dec 31, 2019 | $15.99M | -0.2% |
| Q3 FY2019 | Sep 30, 2019 | $14.60M | +226.6% |
| Q2 FY2019 | Jun 30, 2019 | $15.00M | +285.4% |
| Q1 FY2019 | Mar 31, 2019 | $17.45M | +403.5% |
| Q4 FY2018 | Dec 31, 2018 | $16.03M | +253.9% |
| Q3 FY2018 | Sep 30, 2018 | $4.47M | +118.7% |
| Q2 FY2018 | Jun 30, 2018 | $3.89M | +80.0% |
| Q1 FY2018 | Mar 31, 2018 | $3.47M | +15.2% |
| Q4 FY2017 | Dec 31, 2017 | $4.53M | -63.5% |
| Q3 FY2017 | Sep 30, 2017 | $2.04M | -98.7% |
| Q2 FY2017 | Jun 30, 2017 | $2.16M | – |
| Q1 FY2017 | Mar 31, 2017 | $3.01M | – |
| Q4 FY2016 | Dec 31, 2016 | $12.40M | – |
| Q3 FY2016 | Sep 30, 2016 | $162.35M | – |
See a number that looks wrong?